Search research articles
Contact Us
Filters
Showing results (41-50 of 67) with videos related to
Page
of 7
Sort By:
Chemistry (Weinheim an Der Bergstrasse, Germany)
|
March 7, 2018
Salicylic Acid-Based Polymeric Contrast Agents for Molecular Magnetic Resonance Imaging of Prostate Cancer
Sangeeta Ray Banerjee, Xiaolei Song, Xing Yang, et al.
Science Advances
|
July 9, 2019
Imaging CAR T cell therapy with PSMA-targeted positron emission tomography
Il Minn, David J Huss, Hye-Hyun Ahn, et al.
Journal of Labelled Compounds & Radiopharmaceuticals
|
February 12, 2021
Process validation, current good manufacturing practice production, dosimetry, and toxicity studies of the carbonic anhydrase IX imaging agent [<sup>111</sup> In]In-XYIMSR-01 for phase I regulatory approval
Ravindra A De Silva, Michael A Gorin, Ronnie C Mease, et al.
Scientific Reports
|
May 7, 2021
Nanoparticle-mediated tumor cell expression of mIL-12 via systemic gene delivery treats syngeneic models of murine lung cancers
Hye-Hyun Ahn, Christine Carrington, Yizong Hu, et al.
ACS Applied Materials & Interfaces
|
June 24, 2021
Scalable Purification of Plasmid DNA Nanoparticles by Tangential Flow Filtration for Systemic Delivery
Heng-Wen Liu, Yizong Hu, Yong Ren, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine
|
March 3, 2018
<sup>18</sup>F-XTRA PET for Enhanced Imaging of the Extrathalamic α4β2 Nicotinic Acetylcholine Receptor
Jennifer M Coughlin, Stephanie Slania, Yong Du, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine
|
June 30, 2019
Preclinical Evaluation of <sup>203/212</sup>Pb-Labeled Low-Molecular-Weight Compounds for Targeted Radiopharmaceutical Therapy of Prostate Cancer
Sangeeta Ray Banerjee, Il Minn, Vivek Kumar, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine
|
June 5, 2021
An Improved <sup>211</sup>At-Labeled Agent for PSMA-Targeted α-Therapy
Ronnie C Mease, Choong Mo Kang, Vivek Kumar, et al.
Oncotarget
|
September 30, 2015
Imaging of carbonic anhydrase IX with an 111In-labeled dual-motif inhibitor
Xing Yang, Il Minn, Steven P Rowe, et al.
Elife
|
May 20, 2025
ME3BP-7 is a targeted cytotoxic agent that rapidly kills pancreatic cancer cells expressing high levels of monocarboxylate transporter MCT1
Jordina Rincon-Torroella, Marco Dal Molin, Brian Mog, et al.
Page
of 7
Search research articles
Search
Showing results (41-50 of 67) with videos related to
Sort By:
Page
of 7
Chemistry (Weinheim an Der Bergstrasse, Germany)
|
March 7, 2018
Salicylic Acid-Based Polymeric Contrast Agents for Molecular Magnetic Resonance Imaging of Prostate Cancer
Sangeeta Ray Banerjee, Xiaolei Song, Xing Yang, et al.
Science Advances
|
July 9, 2019
Imaging CAR T cell therapy with PSMA-targeted positron emission tomography
Il Minn, David J Huss, Hye-Hyun Ahn, et al.
Journal of Labelled Compounds & Radiopharmaceuticals
|
February 12, 2021
Process validation, current good manufacturing practice production, dosimetry, and toxicity studies of the carbonic anhydrase IX imaging agent [<sup>111</sup> In]In-XYIMSR-01 for phase I regulatory approval
Ravindra A De Silva, Michael A Gorin, Ronnie C Mease, et al.
Scientific Reports
|
May 7, 2021
Nanoparticle-mediated tumor cell expression of mIL-12 via systemic gene delivery treats syngeneic models of murine lung cancers
Hye-Hyun Ahn, Christine Carrington, Yizong Hu, et al.
ACS Applied Materials & Interfaces
|
June 24, 2021
Scalable Purification of Plasmid DNA Nanoparticles by Tangential Flow Filtration for Systemic Delivery
Heng-Wen Liu, Yizong Hu, Yong Ren, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine
|
March 3, 2018
<sup>18</sup>F-XTRA PET for Enhanced Imaging of the Extrathalamic α4β2 Nicotinic Acetylcholine Receptor
Jennifer M Coughlin, Stephanie Slania, Yong Du, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine
|
June 30, 2019
Preclinical Evaluation of <sup>203/212</sup>Pb-Labeled Low-Molecular-Weight Compounds for Targeted Radiopharmaceutical Therapy of Prostate Cancer
Sangeeta Ray Banerjee, Il Minn, Vivek Kumar, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine
|
June 5, 2021
An Improved <sup>211</sup>At-Labeled Agent for PSMA-Targeted α-Therapy
Ronnie C Mease, Choong Mo Kang, Vivek Kumar, et al.
Oncotarget
|
September 30, 2015
Imaging of carbonic anhydrase IX with an 111In-labeled dual-motif inhibitor
Xing Yang, Il Minn, Steven P Rowe, et al.
Elife
|
May 20, 2025
ME3BP-7 is a targeted cytotoxic agent that rapidly kills pancreatic cancer cells expressing high levels of monocarboxylate transporter MCT1
Jordina Rincon-Torroella, Marco Dal Molin, Brian Mog, et al.
Page
of 7